Conmed (CNMD) Net Cash Flow (2010 - 2026)

Conmed has reported Net Cash Flow for 17 years, with the latest figure at -$5.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 148.72% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 141.97% YoY), and the FY2025 full-year result was $13.9 million, up 382.42% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$5.0 million, down from $1.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $29.6 million in Q2 2022, with the low at -$18.5 million in Q3 2022.
• Historically, Net Cash Flow has averaged $914352.9 across 5 years, with a median of $1.4 million in 2023.
• The largest YoY upside for Net Cash Flow was 466.12% in 2024 against a maximum downside of 421.96% in 2024.
• Conmed's Net Cash Flow stood at -$6.4 million in 2022, then declined by 12.89% to -$7.2 million in 2023, then slumped by 62.91% to -$11.8 million in 2024, then jumped by 115.75% to $1.9 million in 2025, then slumped by 368.23% to -$5.0 million in 2026.
• The last three Net Cash Flow figures came in at -$5.0 million (Q1 2026), $1.9 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.